Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can we decrease amphotericin nephrotoxicity?

S Costa1, M Nucci

  • 1Grupo de Controle de Infecção Hospitalar, Departamento de Doenças Infecciosas e Parasitárias, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo.

Current Opinion in Critical Care
|January 24, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for new phenomena with the <math></math> variable in the all-hadronic final state produced in proton-proton collisions at <math> </math> <math></math>.

The European physical journal. C, Particles and fields·2020
Same author

Measurement of the triple-differential dijet cross section in proton-proton collisions at <math> </math> and constraints on parton distribution functions.

The European physical journal. C, Particles and fields·2020
Same author

Search for dark matter produced in association with heavy-flavor quark pairs in proton-proton collisions at <math> </math>.

The European physical journal. C, Particles and fields·2020
Same author

Searches for physics beyond the standard model with the <math></math> variable in hadronic final states with and without disappearing tracks in proton-proton collisions at <math> </math>.

The European physical journal. C, Particles and fields·2020
Same author

Search for Physics beyond the Standard Model in Events with Overlapping Photons and Jets.

Physical review letters·2020
Same author

Measurement of the average very forward energy as a function of the track multiplicity at central pseudorapidities in proton-proton collisions at <math> </math>.

The European physical journal. C, Particles and fields·2019
Same journal

How to establish and run a national ICU benchmarking registry.

Current opinion in critical care·2026
Same journal

Cardiogenic shock - toward phenotype-directed, precision management.

Current opinion in critical care·2026
Same journal

The future of critical care nutrition: from calorie counting to precision personalized metabolism therapy.

Current opinion in critical care·2026
Same journal

Editorial introduction.

Current opinion in critical care·2026
Same journal

Generative artificial intelligence for outcome prediction in critical care: the future is now?

Current opinion in critical care·2026
Same journal

Feeding under support in critical care illness: metabolic and nutritional management during extracorporeal membrane oxygenation and continuous renal replacement therapy.

Current opinion in critical care·2026
See all related articles

Amphotericin B treats fungal infections but can harm kidneys. Lipid formulations of Amphotericin B significantly reduce this nephrotoxicity, offering a safer treatment option for at-risk patients.

Area of Science:

  • Pharmacology
  • Nephrology
  • Mycology

Background:

  • Amphotericin B (AmB) is a primary antifungal agent for systemic infections.
  • Nephrotoxicity is a significant adverse effect of AmB, linked to dose, diuretics, baseline creatinine, and co-administered drugs.
  • Pathogenesis theories include direct epithelial cell membrane effects and vasoconstriction.

Purpose of the Study:

  • To review strategies aimed at mitigating AmB-induced nephrotoxicity.
  • To evaluate the efficacy of different AmB administration methods in preventing renal damage.

Main Methods:

  • Review of randomized trials testing various AmB nephrotoxicity reduction strategies.
  • Comparison of conventional AmB with lipid emulsions and lipid formulations.

Related Experiment Videos

Main Results:

  • Lipid formulations of Amphotericin B demonstrated a significant reduction in nephrotoxicity compared to conventional AmB.
  • Other strategies like sodium supplementation and dopamine showed varied results.

Conclusions:

  • Lipid formulations represent a safer alternative for Amphotericin B administration, minimizing renal toxicity.
  • High cost of lipid formulations limits their widespread use, reserving them for high-risk individuals.